Clinical trial
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With…
NCT00002870 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00002870 |
|---|---|
| Title | High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer |
| Official title | A RANDOMIZED, MULTI-CENTRE PHASE III TRIAL TO EVALUATE THE ROLE OF INTENSIFIED THERAPY WITH AUTOLOGOUS TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS IN ADVANCED OR METASTATIC BREAST CANCER RESPONDING TO INDUCTION CHEMOTHERAPY |
| Lead sponsor | UNICANCER, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, cyclophosphamide, epirubicin hydrochloride, fluorouracil, thiotepa, peripheral blood stem cell transplantation |
| Enrollment | 180 |
| Start date | Dec 1, 1994 |
| Primary completion | Jan 1, 2002 |
| Completion | Jan 1, 2002 |
| First posted | May 12, 2004 |
| Last update posted | Dec 16, 2014 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: